SXC Health Solutions reports on the status of its bid for a PBM contract with a State Medicaid program

LISLE, IL, April 28 /PRNewswire-FirstCall/ - SXC Health Solutions, Corp. ("SXC" or the "Company") (NASDAQ: SXCI, TSX: SXC), a leading provider of pharmacy benefits management services, announces that it has been notified by a State Medicaid program that it has the leading competitive bid to be considered for the awarding of a three-year $35 million Pharmacy Benefits Manager (PBM) contract.

While there is no assurance as to when, if at all, a contract will be awarded to the Company, the contract would be for three years with an expected launch date of October 1, 2008, and would include two one-year extension options. Further details of the anticipated contract will be available if executed.

About SXC Health Solutions

SXC Health Solutions, Corp. (SXC) is a leading provider of pharmacy benefits management (PBM) services and healthcare IT solutions to the healthcare benefits management industry. The Company's product offerings and solutions combine a wide range of software applications, application service provider (ASP) processing services and professional services, designed for many of the largest organizations in the pharmaceutical supply chain, such as Federal, provincial, and, state and local governments, pharmacy benefit managers, managed care organizations, retail pharmacy chains and other healthcare intermediaries. SXC is based in Lisle, Illinois with locations in; Scottsdale, Arizona; Warminster, Pennsylvania; Alpharetta, Georgia; Milton, Ontario and Victoria, British Columbia. For more information please visit www.sxc.com.

SOURCE SXC Health Solutions, Inc.

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.